Cardiotoxicity associated with paclitaxel/trastuzumab combination therapy.
Jerian
S
S
Keegan
P
P
D000911:Antibodies, Monoclonal / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D017239:Paclitaxel / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003520:Cyclophosphamide; D000068878:Trastuzumab; D017239:Paclitaxel